The potential relationship between variation in the env V3-V4 region of HIV-1 predominant strains in China and virus biological feature

Chinese Journal of Microbiology and Immunology

Volumn 25, Issue 3, 2005, Pages 185-189

  Xing, Hui ^a   Liang, Hao ^b   Hong, Kun Xue ^b   Wei, Min ^b   Zhao, Quan Bi ^b   Feng, Yi ^b   Chen, Jian Ping ^b   Quan, Yu ^b   Teng, Tao ^b   Shao, Yi Ming ^b  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b NONE

Author keywords

Genetic variation; Human immunodeficiency virus type 1; Phenotype; Subtype

Indexed keywords

AMINO ACID; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; GENE PRODUCT; RECEPTOR;

AMINO ACID SEQUENCE; ARTICLE; CHINA; COMPARATIVE STUDY; ENVELOPE GENE; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC VARIABILITY; GLYCOSYLATION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; POLYMERASE CHAIN REACTION; VIRUS STRAIN;

EID: 22044438277     PISSN: 02545101     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Hwang SS, Boyle TJ, Lyerly HK, et al. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science, 1991, 253 (5015): 71-74.
2. Cocchi F, DeVico A, Garzino-Deino A, et al. The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine mediated blockade of infection. Nature Med, 1996, 2 (11): 1244-1247.
3. Fouchier RA, Groenink M, Kootstra NA, et al. Phenotype-associated sequence variation in the third variable region of the human immunodeficiency virus typel gp120 molecule. J Virol, 1992, 66 (5): 3183-3187.
4. Ou CY, Takebe Y, Weniger BG, et al. Independent introduction of two major HIV-1 genotypes into distinct high risk populations in Thailand. Lancet, 1993, 341(8854): 1171-1174.
5. Subbarao S, Vanichseni S, Hu DJ, et al. Genetic characterization of incident HIV type 1 subtype E and B strains from a prospective cohort of injecting drug users in Bangkok, Thailand. AIDS Res Hum Retroviruses, 2000, 16 (8): 699-707.
6. Pollakis G, Kang S, Kliphuis A, et al. N-linked glycosylation of the HIV type-1 gp120 envelope glycoprotein as a major determinant of CCR5 and CXCR4 coreceptor utilization. J Biol Chem, 2001, 276 (16): 13433-13441.
7. Peeters M, Vincent R, Perret JL, et al. Evidence for differences in MT2 cell tropism according to genetic subtypes of HIV-1: syncytium- inducing variants seem rare among subtype C HIV-1 viruses. J Acquir Immune Defic Syndr Hum Retrovirol, 1999, 20 (2): 115-121.
8. Xiao L, Owen SM, Goldman I, et al. CCR5 coreceptor usage of non-syncytium-inducing primary HIV-1 is independent of phylogenetically distinct global HIV-1 isolates: Delineation of consensus motif in the V3 domain that predicts CCR5 usage. Virology, 1998, 240 (1): 83-92.
9. Van't Wout AB, Kootstra NA, Mulder-Kaminga GA, et al. Macrophage tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission. J Clin Invest, 1994, 94 (5): 2060-2067.
10. Yu XF, Wang Z, Vlahov D, et al. Infection with dual-tropic human immunodeficiency virus type 1 variants associated with rapid total T cell decline and disease progression in injecting drug users. J Infect Dis, 1998, 178 (2): 338-396.